Estrella Immunopharma, Inc. (ESLA): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0001172661-26-002144

Filer

Estrella Immunopharma, Inc. (CIK 1844417)